CCNA2 mRNA was reported to be distinctly upregulated in non-small-cell lung cancer (NSCLC) specimens and cell lines, but no prognostic value of CCNA2 in NSCLC has been found (Liu et al., 2019; Du et al., 2020). This evidence concerns the gene CCNA2 and non-small cell lung carcinoma.